ExeVir's XVR011, a best in class nanobody-based biology that broadly neutralizes SARS-COV-1 and SARS-COV-2

Project Information

XVR011 Phase 2

Grant agreement ID: 101045949

DOI

10.3030/101045949

Project closed

EC signature date 15 November 2021

Start date 1 December 2021

End date 30 November 2022

Funded under

• Health

Total cost

€ 9 902 750,00

EU contribution

€ 9 902 750,00

Coordinated by

EXEVIR BIO
Belgium

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Other (1)

Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that bind a conserved membrane proximal epitope of the spike

Author(s): Sieglinde De Cae et al.
Published in: COLD SPRING HARBOUR LABORATORY, 2023
Publisher: bioRxiv
DOI: 10.1101/2023.03.10.531533

Intellectual Property Rights

Trademark (10)

EXEVYCO

Application/Publication number: US 79319484
Date: 2021-06-29
Applicant(s): EXEVIR BIO

ExeVir Bio

Application/Publication number: EU 018362802
Date: 2020-12-22
Applicant(s): EXEVIR BIO

EXEVYCO

Application/Publication number: BX 01432927
Date: 2021-01-05
Applicant(s): EXEVIR BIO

EXEVYCO

Application/Publication number: WO 1611417
Date: 2021-06-29
Applicant(s): EXEVIR BIO

XPLICOVY

Application/Publication number: BX 01432925
Date: 2021-01-05
Applicant(s): EXEVIR BIO

ExeVir Bio

Application/Publication number: BX 01420345
Date: 2020-09-27
Applicant(s): EXEVIR BIO

ExeVir Bio

Application/Publication number: UK 00003696584
Date: 2021-09-17
Applicant(s): EXEVIR BIO

XPLICOVY

Application/Publication number: US 90701230
Date: 2021-05-10
Applicant(s): EXEVIR BIO

EXEVIR BIO

Application/Publication number: US 90407762
Date: 2020-12-23
Applicant(s): EXEVIR BIO

XPLICOVY

Application/Publication number: WO 1608535
Date: 2021-06-29
Applicant(s): EXEVIR BIO

Patent (4)

PAN-SPECIFIC CORONA VIRUS BINDERS

Application/Publication number: 20 22062980
Date: 2022-05-12
Applicant(s): EXEVIR BIO

CORONA VIRUS BINDERS

Application/Publication number: 21 712040
Date: 2021-02-05
Applicant(s): EXEVIR BIO

ANTIBODY COMPOSITIONS FOR TREATMENT OF CORONA VIRUS INFECTION

Application/Publication number: 20 21087602
Date: 2021-12-23
Applicant(s): EXEVIR BIO

SARBECOVIRUS BINDERS

Application/Publication number: 20 22052919
Date: 2022-02-07
Applicant(s): EXEVIR BIO